Albinism: Modern molecular diagnosis

British Journal of Ophthalmology

Volumn 82, Issue 2, 1998, Pages 189-195

  Carden, Susan M ^a,b   Boissy, Raymond E ^c   Schoettker, Pamela J ^c   Good, William V ^b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b SMITH KETTLEWELL EYE RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MELANIN;

ALBINISM; CHEDIAK HIGASHI SYNDROME; DISEASE CLASSIFICATION; GENETIC LINKAGE; HUMAN; HYPOPIGMENTATION; MELANOGENESIS; OCULAR ALBINISM; OCULOCUTANEOUS ALBINISM; PRIORITY JOURNAL; REVIEW;

EID: 0031966616     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.82.2.189     Document Type: Review

References (89)

1. Oetting WS, Brilliant MH, King RA. The clinical spectrum of albinism in humans. Mol Med Today 1996;2:330-5.
2. Jeffery G, Schutz G, Montoliu L. Correction of abnormal retinal pathways found with albinism by introduction of a functional tyrosinase gene in transgenic mice. Dev Biol 1994;166:460-4.
3. Boissy RE, Nordlund JJ. Biology of melanocytes. In: Arndt KA, LeBoit PE, Robinson JK, Wintroub BU, eds. Cutaneous medicine and surgery: an integrated program in dermatology. Philadelphia: Saunders, 1995:1203-9.
4. Hogan MJ, Alvarado JA, Weddell JE. Histology of the human eye; an atlas and texbook. Philadelphia: Saunders, 1971:38-40.
5. Zhao H, Boissy RE. Distinguishing between the catalytic potential and apparent expression of tyrosinase activities. Am J Med Sci 1994;308:322-30.
6. Orlow SJ, Zhou BK, Chakraborty AK, et al. High molecular-weight forms of tyrosinase and the tyrosinase-related proteins: evidence for a melanogenic complex. J Invest Dermatol 1994;103:196-201.
7. Winder AJ, Kobayashi T, Tsukamoto K, et al. The tyrosinase gene family: interactions of melanogenic proteins to regulate melanogenesis. Cell Mol Biol Res 1994;40:613-26.
8. Rinchik EM, Bultman SJ, Horsthemke B, et al. A gene for the mouse pink-eyed dilution locus and for human type II oculocutaneous albinism. Nature 1993;361:72-6.
9. Gahl WA, Potterf B, Durham-Pierre D, Brilliant MH, Hearing VJ. Melanosomal tyrosine transport in normal and pink-eyed dilution murine melanocytes. Pigment Cell Res 1995;8:229-33.
10. Spritz RA. Molecular genetics of oculocutaneous albinism. Semin Dermatol 1993;12:167-72.
11. King RA, Hearing VJ, Creel DJ, Oetting WS. Albinism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease. 7th ed. Vol II. New York: McGraw Hill, 1995:4353-92.
12. Hearing VJ, Tsukamoto K. Enzymatic control of pigmentation in mammals. FASEB J 1991;5:2902-9.
13. Hu F, Hanifin JM, Prescott GH, Tongue AC. Yellow mutant albinism: cytochemical, ultrastructural, and genetic characterization suggesting multiple allelism. Am J Hum Genet 1980;32:387-95.
14. Spritz RA. Molecular genetics of oculocutaneous albinism. Hum Mol Genet 1994;3:1469-75.
15. Nance WE, Jackson CE, Witkop CJ Jr. Amish albanism: a distinctive autosomal recessive penotype. Am. J Hum Genet 1970;22:579-86.
16. Giebel LB, Spritz RA. The molecular basis of type I (tyrosinase-deficient) human oculocutaneous albinism. Pigment Cell Res 1992;Suppl 2:101-6.
17. Ramsay M, Colman MA, Steven G, et al. The tyrosinase-positive oculocutaneous albinism locus maps to chromosome 15q11.2-q12. Am J Hum Genet 1992;51:879-84.
18. Lee ST, Nicholls RD, Bundey S, et al. Mutations in the P gene in oculocutaneous albinism, ocular albinism, and Prader-Willi syndrome plus albinism. N Engl J Med 1994;330:529-34.
19. Hoyt CS, Good WV. Visual factors in developmental delay and neurological disorders in infants. In: Simons K, ed. Infant vision: basic and clinical research. Committee on Vision, Commision on Behavioral and Social Sciences and Education, National Research Council. New York: Oxford University Press, 1993:505-12.
20. Tresidder J, Fielder AR, Nicholson J. Delayed visual maturation: ophthalmic and neurodevelopmental aspects. Dev Med Child Neurol 1990;32:872-81.
21. Boissy RE, Zhau H, Oetting WS, et al. Mutation in and lack of expression of tyrosinase-related protein-1 (TRP-1) in melanocytes from an individual with brown oculo-cutaneous albinism: a new subtype of albinism classified as "OCAS". Am J Hum Genet 1996;58:1145-56.
22. Jackson IJ. A cDNA encoding tyrosinase-related protein maps to the brown locus in mice. Proc Natl Acad Sci USA 1988;85:4392-6.
23. Murty VV, Bouchard B, Mathew S, Vijayasaradhi S, Houghton AN. Assignment of the human TYRP (brown) locus to chromosome region 9p23 by nonradioactive in situ hybridization. Genomics 1992;13:227-9.
24. Jimenez-Cervantes C, Solano F, Kobayashi T, et al. A new enzymatic function in the melanogenic pathway:the DHICA oxidase activity of tyrosinase related protein-1 (TRP1). J Biol Chem 1994;269:17993-8001.
25. Kobayashi T, Urabe K, Winder AJ, et al. Tyrosinase-related protein 1 (TRP1) functions as a DHICA oxidase in melanin biosynthesis. EMBO J 1994;13:5818-25.
26. Zhao H, Zhao Y, Nordlund JJ, Boissy RE. Human TRP-1 has tyrosine hydroxylase activity but no dopa oxidase activity. Pigment Cell Res 1994;7:131-40.
27. Zhao H, Eling DJ, Medrano EE, Boissy RE. Retroviral infection with human tyrosinase-related protein-1 (TRP-1) cDNA upregulates tyrosinase activity and melanin synthesis in a trp-1-deficient melanoma cell line. J Invest Dermatol 1996;106:744-52.
28. Bergen AA, Samanns C, Van Dorp DB, et al. Localization of the X-linked ocular albinism gene (OA1) between DXS278/DXS237 and DXS143/ DXS16 by linkage analysis. Ophthalmic Paediat Genet 1990;11:165-70.
29. Bergen AA, Samanns C, Schuurman EJ, et al. Multipoint linkage analysis in X-linked ocular albinism of the Nettleship-Falls type. Hum Genet 1991;88: 162-6.
30. Schnur RE, Nussbaum RL, Anson-Catwright L, et al. Linkage analysis in X-linked ocular albinism. Genomics 1991;9:605-13.
31. Charles SJ, Moore AT, Yates JR. Genetic mapping of X linked ocular albinism: linkage analysis in British families. J Med Genet 1992;29:552-4.
32. Charles SJ, Green JS, Grant W, Yates JR, Moore AT. Clinical features of affected males with X linked ocular albinism. Br J Ophthalmol 1993;77:222-7.
33. Bassi MT, Schiaffino MV, Renieri A, et al. Cloning of the gene for ocular albinism type 1 from the distal short arm of the X chromosome. Nat Genet 1995;10:13-9.
34. Charles SJ, Moore AT, Zhang Y, et al. Carrier detection in X linked ocular albinism using linked DNA polymorphisms. Br J Ophthalmol 1994;78:539-41.
35. Charles SJ, Moore AT, Grant JW, Yates JR. Genetic counselling in X-linked ocular albinism:clinical features of the carrier state. Eye 1992;6:75-9.
36. Schnur RE, Wick PA, Bailey C, et al. Phenotypic variability in X-linked ocular albinism:relationship to linkage genotypes. Am J Hum Genet 1994;55:484-96.
37. Schiaffino MV, Bassi MT, Galli L, et al. Analysis of the OA1 gene reveals mutations in only one-third of patients with X-linked ocular albinism. Hum Mol Genet 1995;4:2319-25.
38. Fukai K, Holmes SA, Lucchese NJ, et al. Autosomal recessive ocular albinism associated with a functionally significant tyrosinase gene polymorphism. Nat Genet 1995;9:92-5.
39. Giebel LB, Tripathi RK, King RA, Spritz RA. A temperature-sensitive tyrosinase in human albinism: a human homologue to the Siamese cat and the Himalayan mouse. J Clin Invest 1991;87:1119-22.
40. Gardner JM, Nakatsu T, Gondo Y, et al. The mouse pink-eyed dilution gene: association with human Prader-Willi and Angelmann syndromes. Science 1992;257:1121-4.
41. Buntinx IM, Hennekam RC, Brouwer OF, et al. Clinical profile of Angelman syndrome at different ages. Am J Med Genet 1995;56:176-83.
42. Prader A, Labhart A, Willi H. Ein Syndrom von Adipositas, Kleinwuchs, Kryptorchismus und Oligophrenie nach Myotonicartigem Zustand im Neugelborenalter. Schweiz Med Wochenschr 1956;86:1260-2.
43. Holm VA. The diagnosis of Prader-Willi syndrome. In: Holm VA, Sulzbacher S, Pipes PL, eds. Prader-Willi syndrome. Baltimore: University Press, 1981:27-44.
44. Cassidy SB. Prader-Willi syndrome. Curr Probl Pediatr 1984;14:1-55.
45. Krautmann PJ, Barenie JT, Myers DR. Clinical manifestations of Prader-Willi syndrome. J Pedodont 1981;5:256-61.
46. Jorde LB, Carey JC, White RL. Medical genetics. St. Louis: Mosby, 1995:74-6.
47. Bouloux PM, Kirk J, Munroe P, et al. Deletion analysis maps ocular albinism proximal to the steroid sulphatase locus. Clin Genet 1993;43:169-73.
48. Meindl A, Hosenfeld D, Bruckl W, et al. Analysis of a terminal Xp22.3 deletion in a patient with six monogenic disorders:implications for the mapping of X linked ocular albinism. J Med Genet 1993;30:838-42.
49. Sunohara N, Sakuragawa N, Satoyoshi E, Tanae A, Shapiro LJ. A new syndrome of anosmia, ichthyosis, hypogonadism, and various neurological manifestations with deficiency of steroid sulfatase and arylsulfatase C. Ann Neurol 1986;19:174-81.
50. Winship IM, Babaya M, Ramesar RS. X-linked ocular albinism and sensorineural deafness: linkage to Xp22.3. Genomics 1993;18:444-5.
51. Wapenaar MC, Bassi MT, Schaefer L, et al. The genes for X-linked ocular albinism (OA1) and microphthalmia with linear skin defects (MLS): cloning and characterization of the critical regions. Hum Mol Genet 1993;2: 947-52.
52. Fukai K, Oh J, Karim MA, et al. Homozygosity mapping of the gene for Chediak-Higashi syndrome to chromosome 1q42-q44 in a segment of conserved synteny that includes the mouse beige locus (bg). Am J Hum Genet 1996;59:620-4.
53. Barrat FJ, Auloge L, Pastural E, et al. Genetic and physical mapping of the Chediak-Higashi syndrome on chromosome 1q42-43. Am J Hum Genet 1996;59:625-32.
54. Nagle DL, Karim MA, Woolf EA, et al. Identification and mutation analysis of the complete gene for Chediak-Higashi syndrome. Nat Genet 1996;14:307-11.
55. Barbosa MD, Nguyen QA, Tchernev VT, et al. Identification of the homologous beige and Chediak-Higashi syndrome genes. Nature 1996;382:262-5.
56. Uyama E, Hirano T, Ito K, et al. Adult Chediak-Higashi syndrome presenting as parkinsonism and dementia. Acta Neurol Scand 1994;89:175-83.
57. Zhao H, Boissy YL, Abdel-Malek Z, et al. On the analysis of the pathophysiology of Chediak-Higashi syndrome. Defects expressed by cultured melanocytes. Lab Invest 1994;71:25-34.
58. Orlow SJ. Melanosomes are specialized members of the lysosomal lineage of organelles. J Invest Dermatol 1995;105:3-7.
59. Creel DJ, Conlee JW, Collier LL, Prieur DJ. Auditory brainstem responses in cats with Chediak-Higashi syndrome. Acta Otolaryngol (Stockh) 1994;114: 373-5.
60. Creel D, Garber SR, King RA, Witkop CJ Jr. Auditory brainstem anomalies in human albinos. Science 1980;209:1253-5.
61. Creel D, Conlee JW, Parks TN. Auditory brainstem anomalies in albino cats. I Evoked potential studies. Brain Res 1983;260:1-9.
62. Conlee JW, Parks TN, Romero C, Creel DJ. Auditory brainstem anomalies in albino cats. II Neuronal atropy in the superior olive. J Comp Neurol 1984;225:141-8.
63. Conlee JW, Parks TN, Creel DJ. Reduced neuronal size and dendritic length in the medial superior olivary nucleus of albino rabbits. Brain Res 1986;363:28-37.
64. Baker GE, Guillery RW. Evidence for the delayed expression of a brainstem abnormality in albino ferrets. Exp Brain Res 1989;74:658-62.
65. Fukai K, Oh J, Frenk E, Almodovar C, Spritz RA. Linkage disequilibrium mapping of the gene for Hermansky-Pudlak syndrome to chromosome 10q23.1-q23.3. Hum Mol Genet 1995;4:1665-9.
66. Izquierdo NJ, Townsend W, Hussels IE. Ocular findings in the Hermansky-Pudlak syndrome. Trans Am Ophthalmol Soc 1995;93:191-200.
67. Witkop CJ, Nunez Babcock M, Rao GH, et al. Albinism and Hermansky-Pudlak syndrome in Puerto Rico. Bol Assoc Med P Rico 1990;82:333-9.
68. Witkop CJ Jr, White JG, King RA. Oculocutaneous albinism. In: Nyhan WL, ed. Heritable disorders of amino acid metabolism:patterns of clinical expression and genetic variation. New York: Wiley, 1974:177-261.
69. Witkop CJ, Almadovar C, Pineiro B, Nunez Babcock M. Hermansky-Pudlak syndrome (HPS). An epidemiological study. Ophthalmic Paediat Genet 1990;11:245-50.
70. Izquierdo NJ, Royuela MA, Maumenee IH. Possible origins of the gene of Hermansky-Pudlak in Puerto Rico. Puerto Rico Health Sci J 1993;12:147-8.
71. Wildenberg SC, Oetting WS, Almodovar C, et al. A gene causing Hermansky-Pudlak syndrome in a Puerto Rican population maps to chromosome 10q2. Am J Hum Genet 1995;57:755-65.
72. Oh J, Bailin T, Fukai K, et al. Positional cloning of a gene for Hermansky-Pudlak syndrome, a disorder of cytoplasmic organelles. Nat Genet 1996;14:300-6.
73. Boissy RE, Nordlund JJ. The molecular basis of congenital hypopigmentary disorders in humans - a review. Pigment Cell Res 1997;10:12-24.
74. Tassabehji M, Read AP, Newton VE, et al. Waardenburg's syndrome patients have mutations in the human homolgue of the Pax-3 paired box gene. Nature 1992;355:635-6.
75. Hoth CF, Milunsky A, Lipsky N, et al. Mutations in the paired domain of the human PAX3 gene cause Klein-Waardenburg syndrome (WS-III) as well as Waardenburg syndrome type I (WS-I). Am J Hum Genet 1993;52:455-62.
76. Hughes AE, Newton VE, Liu XZ, Read AP. A gene for Waardenburg syndrome type 2 maps close to the human homologue of the microphthalmia gene at chromosome 3p12-p14.1. Nat Genet 1994;7:509-12.
77. Tassabehji M, Newton VE, Read AP. Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene. Nat Genet 1994; 8:251-5.
78. Attie T, Till M, Pelet A, et al. Mutation of the endothelin-receptor B gene in Waardenburg-Hirschsprung disease. Hum Mol Genet 1995;4:2407-9.
79. Puffenberger EG, Hosoda K, Washington SS, et al. A misssense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease. Cell 1994;79:1257-66.
80. Puffenberger EG, Kauffman ER, Bolk S, et al. Identiry-by-descent and association mapping of a recessive gene for Hirschsprung disease on human chronosome 13q22. Hum Mol Genet 1994;3:1217-25.
81. Shiono T, Tsunoda M, Chida Y, Nakazawa M, Tamai M. X linked ocular albinism in Japanese patients. Br J Ophthalmol 1995;79:139-43.
82. Kriss A, Russell-Eggitt I, Taylor D. Childhood albinism. Visual electrophysiological features. Ophthalmic Pediat Genet 1990;11:185-92.
83. Abadi RV, Dickinson CM, Pascal E, Papas E. Retinal image quality in albinos. A review. Ophthalmic Pediat Genet 1990;11:171-6.
84. Sretavan DW, Feng L, Pure E, Reichardt LF. Embryonic neurons of the developing optic chiasm express L1 and CD44, cell surface molecules with opposing effects on retinal axon grosvth. Neuron 1994;12:957-75.
85. Sretavan DW, Pure E, Siegel MW, Reichardt LF. Disruption of retinal axon ingrowth by ablation of embryonic mouse optic chiasm neurons. Science 1995;269:98-101.
86. LaVail JH, Nixon RA, Sidman RL. Genetic control of retinal ganglion cell projections. J Comp Neurol 1978;182:399-422.
87. Marcus RC, Wang LC, Mason CA. Retinal axon divergence in the optic chiasm:midline cells are unaffected by the albino mutation. Development 1996;122:859-68.
88. Kugelman TP, van Scott EJ. Tyrosinase activity in melanocytes of human albinos. J Invest Dermatol 1961;37:73-6.
89. King RA, Witkop CJ Jr. Hairbulb tyrosinase activity in oculocutaneous albinism. Nature 1976;263:69-71.